{"id":"W3120915669","doi":"10.1093/ofid/ofaa439.426","title":"116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study","year":2020,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Rilpivirine; Medicine; Adverse effect; Tolerability; Human immunodeficiency virus (HIV); Internal medicine; Viral load; Antiretroviral therapy; Virology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004252359,0.0004573895,0.0008975092,0.0001060822,0.0003244868,0.0002047162,0.0002513211,0.0001123105,0.00003003989],"category_scores_gemma":[0.000924886,0.0003511189,0.0001532259,0.000486282,0.000168554,0.000597394,0.0006279889,0.0004205196,0.00001411871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00025479,"about_ca_system_score_gemma":0.0004619272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005824372,"about_ca_topic_score_gemma":0.006643866,"domain_scores_codex":[0.9971264,0.0006407063,0.0006155557,0.0007600252,0.0003989964,0.0004582874],"domain_scores_gemma":[0.9972748,0.001517267,0.0004116233,0.0004296714,0.0001013985,0.000265228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008265,0.00159287,0.9688638,0.00005367555,0.0006915945,0.0009064731,0.005548935,0.00001495666,0.0001066218,0.000009010175,0.0001805006,0.01376651],"study_design_scores_gemma":[0.01494348,0.0007818367,0.9756941,0.0004822998,0.0005377991,0.00002379099,0.005602086,0.0002465564,0.001008002,0.00001830434,0.0002897887,0.0003719299],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862131,0.0002638362,0.00008416457,0.002353597,0.00008284089,0.002474834,0.0008944194,0.00008563651,0.007547608],"genre_scores_gemma":[0.9986891,0.0001029994,0.00005760946,0.0002170647,0.00007208493,0.00008628147,0.0003284138,0.00005710116,0.0003893846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01339458,"threshold_uncertainty_score":0.9998941,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01793653676494958,"score_gpt":0.2866787662986212,"score_spread":0.2687422295336717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}